Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Intraepithelial Lesions 1Muscle Invasive Bladder Cancer (MIBC) 1Limited Stage Small Cell Lung Cancer 1Helicobacter Infections 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Carcinoma In Situ 1Anus Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

VGX-3100 2Cidofovir 2Biopsy 2Aminolevulinic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2epigallocatechin gallate 1Solutions 1Red Light 1Probiotics 1Polymerase Chain Reaction 1Megestrol Acetate 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gene Expression Profiling 1Gels 1GPI0100 1Folic Acid 1Electroporation Therapies 1Electroporation 1DNA Methylation 1Chemoprevention 1Celecoxib 1Blue Light 1Biological Therapy 1Antigens 1Adjuvants, Pharmaceutic 1Acetic Acid 15-aminolaevulinic acid-n-pentylester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Squamous Intraepithelial Lesions × Probiotics × Clear all
NCT06949800 2026-05-01

CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

University of California, San Francisco

Phase 2 Not yet recruiting
90 enrolled
Gynecologic

Squamous Intraepithelial Lesions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡